RAPPAPORT ANDREW 4/A
4/A · Olema Pharmaceuticals, Inc. · Filed Jun 27, 2022
Insider Transaction Report
Form 4/AAmended
RAPPAPORT ANDREW
Director
Transactions
- Award
Stock Option (right to buy)
2022-06-17+21,520→ 21,520 totalExercise: $3.61Exp: 2032-06-16→ Common Stock (21,520 underlying)
Footnotes (2)
- [F1]This amendment is being filed solely for the purpose of correcting the transaction date and exercise price. The correct transaction date is "June 17, 2022" and the correct exercise price is "$3.61" as shown herein.
- [F2]The shares subject to the option vest in a series of 12 successive equal monthly installments measured from June 17, 2022, subject to the Reporting Person's continuous service through each applicable vesting date. Such shares vest in full on the date of the Issuer's next annual meeting of stockholders if such stock option is not otherwise fully vested by such date, subject to the Reporting Person's continuous service through such vesting date.